Legal Archives - Boston Life Sciences Times

FDA Accepts Tirabrutinib NDA for Relapsed or Refractory PCNSL, Sets December 2026 Decision Date

February 17, 2026

Trinity Named Top Health Sciences Consulting Firm in 2026 Vault Rankings

February 12, 2026

FDA accepts Takeda’s narcolepsy drug application, grants priority review for oveporexton

February 10, 2026

THIS WEEK'S STORIES

Jonathan D. Santoro, M.D., Appointed Chief of Neurology and Co-Director of Neurological Institute at Children’s Hospital Los Angeles

February 12, 2026

MEDIPOST Submits IND Amendment to FDA to Support Phase III Knee Osteoarthritis Trial

February 13, 2026

CyPath Lung Test Shown to Support Clinical Decisions in High-Risk Lung Nodule Case

February 17, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Legal

Applied Medical Wins Antitrust Jury Verdict Against Medtronic

Federal Court Grants WHOOP Preliminary Injunction Against Lexqi

NeoGenomics Says Natera Withdraws Appeal in RaDaR Patent Litigation

Earned Expands Services with Addition of Dental & Medical Counsel, Bringing Specialized Legal Support for Healthcare Professionals

Enveric Biosciences Retains Fish & Richardson to Defend U.S. Patent Linked to Bretisilocin Following AbbVie’s $1.2 Billion Acquisition

Most Read

Turn Therapeutics Names Dr. Robert Redfield Senior Advisor for Health Policy and Regulatory Affairs

vMap-Guided VT Ablation Linked to Improved One-Year Outcomes in EP Europace Study

CyPath Lung Test Shown to Support Clinical Decisions in High-Risk Lung Nodule Case

BIOEMTECH, NorthStar Medical Radioisotopes Sign Supply Deal for Actinium-225

EDITOR PICKS

FDA Accepts Tirabrutinib NDA for Relapsed or Refractory PCNSL, Sets December 2026 Decision Date

Trinity Named Top Health Sciences Consulting Firm in 2026 Vault Rankings

FDA accepts Takeda’s narcolepsy drug application, grants priority review for oveporexton

THIS WEEK'S STORIES

Jonathan D. Santoro, M.D., Appointed Chief of Neurology and Co-Director of Neurological Institute at Children’s Hospital Los Angeles

MEDIPOST Submits IND Amendment to FDA to Support Phase III Knee Osteoarthritis Trial

CyPath Lung Test Shown to Support Clinical Decisions in High-Risk Lung Nodule Case

POPULAR CATEGORY

ABOUT US

FOLLOW US